classical nucleation theory
heterogeneous nucleation
suspension solution
concentric lamination
B. heterogeneous nucleation
aminoglycosides
macrolides
cephalosporins
fluoroquinolones
1000 - 1300 HU density
5 - 10 mm diameter
lower calyx location
mid ureteral location
short skin-to-stone distance (SSD)
end-stage renal failure
a stone in the upper calyx
the presence of a 30 cm, 4.7 Fr ureteral stent in situ
when stones are multiple and/or recurrent
when stones form in childhood
in cases where nephrocalcinosis and urolithiasis are present
all of the above
3 6 %
12 15 %
0.4 0.8 %
0.09 0.14 %
ciprofloxacin
indinavir
thiazides
triamterene
a stone in the lower calyx with a wide mouth of infundibulum and obtuse lower calyx to ureter angle
a stone in an anterior group calyceal diverticulum with thin overlying renal parenchyma
5 mm calcium-containing stone in an intrarenal pelvis and wide UPJ
6 years post anatrophic nephrolithotomy, recurrent mid calyceal stone
wet chemical analysis
thermogravimetry
scanning electron microscopy
none of the above
furosemide
tamsulosin
nifedipine
diclofenac
Proteus mirabilis
E. coli
Pseudomonas aeruginosa
Staphylococcus epidermidis
form due to inspissated smegma
form due to stasis of urinary salts
cause inguinal lymphadenopathy
often associated with phimosis in uncircumcised males
chemical analysis of a recovered stone
hypercalcemia
CT finding
high breakability on ESWL
≥ 2 cm diameter
upper calyx location
Na.urate composition
600 - 800 HU density
left ureterocele
bifid right renal pelvis
neurogenic bladder
bilateral UPJ stenosis
2,8 dihydroxyadenine stones
sulfa medications-induced stones
calcium oxalate stones
matrix stones
Ca.oxalate, Ca.phosphate, Na.urate, cystine
Ca.phosphate, Ca.oxalate, cystine, Na.urate
Ca.oxalate, Ca.phosphate, cystine, Na.urate
Ca.phosphate, Ca.oxalate, Na.urate, cystine
physiological saline 0.9%
glycine 1.5%
balanced salt solution
distilled water
stone size
unrelieved obstruction
infection and septicemia
recurrent stone formation
the energy density of the shock waves as they pass through the skin
the size of the focal point
a & b
none of the above
urate
triple phosphate
oxalate monohydrate
matrix
the surface area of the stones
the volume of the stones
the density of the stones
the number of the stones
matrix
indinavir
brushite
2,8 dihydroxyadenine
2 days
2 weeks
2 months
4 6 hrs.
stones at posterior urethra could be pushed back to the bladder
stones at anterior urethra have to undergo a trial of milking out, using copious intra-urethral xylocaine gel
often respond to a two-week course of tamsulosin
respond to Holmium laser treatment
uncontrollable bleeding
incomplete removal of stones
pneumothorax
colonic perforation
patients should be given large amounts of fluids to hasten stones passage
fluids are given to keep the patient well hydrated
the recommended regimen is 2 L of ringer lactate over 2 hours
fluids are contraindicated if desmopressin (DDAVP) was given
ammonium urate
sodium urate
calcium oxalate
calcium phosphate
transitional epithelium lining minor calyces
transitional epithelium lining major calyces
basement membrane of the loops of Henle
papillary tips of polar pyramids
Ca.phosphate
Ca.oxalate
Na.urate
struvite
should be treated with more analgesics
must undergo metabolic worked out
are unlikely to pass out spontaneously
chemolysis should be tried first